Stockreport

Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop [Seeking Alpha]

Ardelyx, Inc.  (ARDX) 
Last ardelyx, inc. earnings: 3/6 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ardelyx.com/investor-relations
PDF Wainwright downgraded the rating for the biopharmaceutical firm, saying that it anticipates a substantial drop in the company's kidney disease drug Xphozah sales in 1Q25 [Read more]